Caxton Associates (UK)’s Prospect Capital PSEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
592,554
+459,031
+344% +$1.13M 0.03% 347
2026
Q1
$348K Sell
133,523
-576,730
-81% -$1.58M 0.01% 572
2025
Q4
$1.84M Sell
710,253
-466,370
-40% -$1.25M 0.04% 221
2025
Q3
$3.24M Buy
1,176,623
+486,564
+71% +$1.46M 0.08% 115
2025
Q2
$2.19M Buy
690,059
+319,984
+86% +$1.11M 0.06% 172
2025
Q1
$1.52M Buy
+370,075
New +$1.59M 0.05% 226

Other funds holding PSEC

Caxton Associates (UK)'s PSEC Position: Q2 2026 in Review

Caxton Associates (UK) increased its Prospect Capital (PSEC) stake by 344% in Q2 2026, buying an estimated $1.13M and bringing the position to 592,554 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #347.

Caxton Associates (UK) first reported a position in PSEC in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.24M in Q3 2025. 205 funds tracked by Wall St. Rank hold PSEC as of Q2 2026.

  • Caxton Associates (UK) held 592,554 shares of Prospect Capital worth $1.37M as of Q2 2026.
  • Caxton Associates (UK) bought 459,031 Prospect Capital shares in Q2 2026, an estimated $1.13M.
  • Prospect Capital made up 0.03% of Caxton Associates (UK)'s portfolio in Q2 2026, its #347 holding.
  • Caxton Associates (UK) first reported a position in Prospect Capital in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s Prospect Capital position peaked at $3.24M in Q3 2025.
  • 205 funds tracked by Wall St. Rank held Prospect Capital as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.